Audited Integrated Financials for quarter and year ended 31.03.2025
ALBERTDAVD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Albert David Limited reported a sharp decline in full-year FY25 profitability. Revenue from operations fell to Rs. 34,576.80 Lacs from Rs. 36,246.17 Lacs (down ~4.6%), while total income dropped to Rs. 37,534.87 Lacs from Rs. 42,001.38 Lacs due to a steep fall in other income. Profit After Tax collapsed to Rs. 1,720.08 Lacs from Rs. 7,542.01 Lacs (down ~77%), with EPS falling to Rs. 30.14 from Rs. 132.15. The Q4 quarter alone posted a loss of Rs. 1,032.79 Lacs versus a profit of Rs. 1,291.26 Lacs in Q4 FY24. Operating cash flow swung to negative Rs. 2,843.58 Lacs versus positive Rs. 4,550.22 Lacs last year, mainly due to a sharp Rs. 2,028.99 Lacs inventory build-up. The Board has recommended a final dividend of Rs. 5 per share (50%), and reappointed internal, secretarial, and cost auditors for FY26. Statutory auditor M/s. L. B. Jha & Co. issued an unmodified (clean) audit opinion.
Despite a clean audit report and steady dividend, shareholders face a significant earnings decline with profits down over three-quarters and a quarterly loss in Q4. Weak operating cash flow and rising costs may weigh on short-term sentiment, though the stock remains a low-debt, dividend-paying pharmaceutical company.